Posts Tagged ‘Innovation’
What’s Behind the Heat-up in Glaucoma Innovation
Kicking off the sixth annual Glaucoma 360-New Horizons Forum held recently in San Francisco, co-founder and co-chair Adrienne Graves boldly proclaimed, “Glaucoma is hot.” However, over the past few years, glaucoma has been anything but hot. Stone cold may be more like it. Innovation had been sorely lacking and the $5 billion annual global market…
Read MoreIs DR Just the Start for Google Brain?
A team of investigators recently reported online in the Journal of the American Medical Association1 that a Google algorithm allows computers to diagnose diabetic retinopathy (DR) using retina photos. The technology will never replace doctors, but Google hopes it will assist them, especially in underserved areas. Google’s first priority with this technology is to distribute…
Read MoreEncore Vision Delivers Big Payday to Angel Investors
Big winners in Novartis AG’s acquisition of Encore Vision for $465 million are members of a network of angel investors in Fort Worth, TX, that bet $4 million on the presbyopia-correcting eye drop that Encore Vision president and CEO Bill Burns has been working on for about nine years. The $4 million the Cowtown Angels…
Read MoreEye on Five – November Edition
Trump Bump Fuels Biotech, Pharma Stocks Pharma and biotech stocks surged in the week after Donald Trump’s election, with the OIS Index jumping 13% and the NASDAQ Biotech Index surging 11.2%. The gains have since trailed off, but the latter index was still up 8% for November at month-end. Three anticipated policy changes have fueled…
Read MoreWelcome to OIS@AAO 2016
More than 800 leaders of the ophthalmology industry will convene Thursday at the Hyatt Regency Chicago Hotel ballroom for our largest Ophthalmology Innovation Summit of the year. This is the 8th OIS@AAO held prior to the annual meeting of the American Academy of Ophthalmology. Registration and check-in for those attending the Breakfast Breakout Sessions will…
Read MoreFrom the Floor of the 1st OIS@ASRS
A new Ophthalmology Innovation Summit emerged Monday just prior to the start of the annual meeting of the American Society of Retina Specialists. The half-day event drew nearly 250 people to the Marriott Marquis in San Francisco. Retina specialists shared the stage and ballroom with executives from strategics and start-ups, as well as investors with…
Read MoreLudwin Monz, PhD, Discusses Zeiss, its Legacy & Where it Pursues New Innovation
Dr. Ludwin Monz, president and CEO of Carl Zeiss Meditec AG, shares how his company’s long history in ophthalmology helps it pave a path for new markets and technologies. Podcast Guest Ludwin Monz, PhD Dr. Ludwin Monz has been President and CEO of Carl Zeiss Meditec AG since 2010 and was appointed a member of…
Read MoreAbbott Medical Optics Points to Leadership Position
Over the past year, Abbott Medical Optics (AMO) has established a leading share position in the US PC-IOL market, driven by the new low-add-power Tecnis Multifocal IOLs. Outside the US, the early success of the Tecnis Symfony Extended Range of Vision IOL has also contributed to market share gains. A large European multicenter post-market study…
Read MoreBausch + Lomb’s CMO Cal Roberts on How He Uses His MD & Experience to Build the Right Tool Kit for Ophthalmologists
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 088″] Bausch + Lomb’s chief medical officer Calvin Roberts, MD, still thinks like a doc when he’s helping to steer the company’s strategy. Hear how he sees B+L making life simpler for ophthalmologists in the near future. Podcast Guest Calvin W. Roberts, MD Calvin W. Roberts, MD, is Executive Vice President…
Read MoreTom Frinzi’s Plans for AMO & Ophthalmology
Ophthalmology veteran Tom Frinzi joins OISTV to share his reasons for joining Abbott Medical Optics and what the company may be planning in coming years. Video Highlights 00:32 – What brought you to AMO? 1:20 – What are the three Ps? 2:02 – Is there a formula for leading any a company? 3:51 – How…
Read MoreEye Care Priority for J&J
Ashley McEvoy, Company Chair of Vision Care and Diabetes at Johnson & Johnson, joins OISTV to discuss Johnson & Johnson’s commitment to eye health. Video Highlights 00:49 – Emerging areas of interest: lung cancer, diabetes and eye health? 01:00 – What areas in eye care are you looking at? 01:25 – How does expertise in…
Read MoreSteinert Honored for His Career of Innovation
In a packed ballroom at the Intercontinental Hotel, OIS attendees recognized the achievements of one of ophthalmology’s physician-innovators. Roger F. Steinert, MD, was honored as this year’s OIS Lifetime Innovator Award. OIS Co-Chair Bill Link told attendees Steinert “had an impactful career” in ophthalmology. “Roger has been an innovator in our field from the beginning…
Read More